Metformin Hydrochloride API Market
Request Sample Report
Metformin Hydrochloride API Market Size and Growth
The Metformin Hydrochloride API market is experiencing robust growth, driven by rising diabetes prevalence and increased demand for oral diabetes medications. The global market size was valued at approximately USD 1.3 billion in 2022, with a projected CAGR of 6% from 2023 to 2028, reflecting ongoing research and development initiatives. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Wanbury
◍ USV
◍ Shouguang Fukang Pharmaceutical
◍ Vistin Pharma
◍ CR Double-Crane
◍ Keyuan Pharmaceutical
◍ Farmhispania Group
◍ Harman Finochem
◍ Shijiazhuang Polee Pharmaceutical
◍ Aarti Drugs
◍ Exemed Pharmaceuticals
The Metformin Hydrochloride API market features key players like Wanbury, USV, and Shouguang Fukang Pharmaceutical, who supply active pharmaceutical ingredients for diabetes treatment. Their efforts in quality production and global distribution enhance market growth. Aarti Drugs reported revenue of approx. $200 million, while USV's revenue exceeds $300 million.
Request Sample Report
Market Segmentation
By Application
◍ Metformin Hydrochloride ExtendedRelease Tablets
By Product
Others ◍ Metformin Hydrochloride Tablets
Metformin HCL
Metformin DC
◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
